Holen Sie sich die Stockscreener-App
112.71
1.54%
1.71
Handel nachbörslich:
112.00
-0.71
-0.63%
Veradermics Inc Aktie (MANE) Neueste Nachrichten
Veradermics (MANE) holder SR One sells 321,749 shares, cuts stake to 4.9% - Stock Titan
John Childs Sells 100,000 Shares of Veradermics (NYSE:MANE) Stock - MarketBeat
Planned MANE (MANE) insider common stock sale and recent IPO activity - Stock Titan
Veradermics (MANE) director-linked trusts sell 100,000 shares of common stock - Stock Titan
Veradermics (MANE) Stock Forecast and Price Target 2026 - MarketBeat
Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $160 - moomoo.com
Needham Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $164 - Moomoo
Veradermics, Inc SEC Filing (Aug 12, 2026) - stocktitan.net
Veradermics: Q2 Earnings Snapshot - theheraldreview.com
MANE SWOT Analysis: Financial Challenges and Competitive Landsca - GuruFocus
Veradermics Q2 Results: EPS of $(0.58) Beats Estimate - scanx.trade
Veradermics (NYSE: MANE) posts larger loss as cash surges above $800M - Stock Titan
Veradermics Announces Q2 2026 Financial Results in SEC 8-K Filing - Kalkine Media
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - biospace.com
Form 8K VERADERMICS For: 11 August By Investing.com - Investing.com Australia
Veradermics reports Q2 2026 net loss $23.5M; cash $819.9M funds operations into 2030 - TradingView
Veradermics' Q2 Net Loss Widens - marketscreener.com
Earnings Flash (MANE) Veradermics Posts Q2 Net Loss $23.5M, vs. FactSet Est of $26.8M Loss - marketscreener.com
IPO Databook: Veradermics (MANE US)Aug 2026 - Smartkarma
FMR LLC discloses 7.6% Veradermics Inc. (MANE) ownership in Schedule 13G - Stock Titan
Enterprise value to EBIT forward of Veradermics, Incorporated – NYSE:MANE - TradingView
Price to earnings forward of Veradermics, Incorporated – NYSE:MANE - TradingView
Price to sales forward of Veradermics, Incorporated – NYSE:MANE - TradingView
Enterprise value to revenue forward of Veradermics, Incorporated – NYSE:MANE - TradingView
Veradermics (MANE) Positioned to Disrupt Hair Loss Market - Yahoo Finance
Veradermics, Inc. (MANE): Six Months Later: Hair Today, Higher Tomorrow, 2026's Breakout Story - Smartkarma
Veradermics Falls 4.4% as Lock-Up Expiry Appears to Weigh on Shares - Moomoo
Certain Options of Veradermics, Incorporated are subject to a Lock-Up Agreement Ending on 3-AUG-2026. - marketscreener.com
14,570,076 Common Stock of Veradermics, Incorporated are subject to a Lock-Up Agreement Ending on 29-JUL-2026. - marketscreener.com
Veradermics, Incorporated's Lock-Up Period Set To End on August 3rd (NYSE:MANE) - MarketBeat
Veradermics, Incorporated Revenue Breakdown – NYSE:MANE - TradingView
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months - Yahoo Finance
LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $170 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Veradermics shares climb 9% after encouraging female hair loss trial results (MANE) - MSN
Veradermics presents subgroup analysis of hair loss drug trial By Investing.com - Investing.com Canada
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy - Yahoo Finance
Pattern hair-loss study analyzes men under 40 and men 40 and older - Stock Titan
Veradermics Is Maintained at Buy by Citigroup - Moomoo
MANE Maintained by Citigroup -- Price Target Raised to $160 - GuruFocus
Why Veradermics Stock Fell Today - Quiver Quantitative
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss - BioPharma Dive
Veradermics stock jumps again on female hair loss drug win - Clinical Trials Arena
Veradermics jumps after mid-stage trial data for lead drug in female pattern hair loss - MSN
MANE Stock Draws Traders As Volatility And Cash Pile Stand Out - StocksToTrade
Why is MANE stock rising today? - MSN
LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $170 - Moomoo
Why Is MANE Stock Rising Today? - TradingView
Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too - Fierce Pharma
Veradermics (MANE) Sees 13.9% Increase in Stock Price - GuruFocus
Veradermics Hair Loss Pill Shows Strong Phase II Signal in Women - Yahoo Finance
PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday - Benzinga
Veradermics stock rises 9% on positive hair loss trial data By Investing.com - Investing.com Canada
Veradermics (NYSE: MANE) posts strong VDPHL01 Phase 2 female data - Stock Titan
Veradermics stock rises 9% on positive hair loss trial data - Investing.com
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):